NEW YORK (Reuters Health) – Pooled data suggest that nonsteroidal anti-inflammatory drugs (NSAIDs) can augment antipsychotic treatment and reduce schizophrenia symptom severity, Dutch researchers report in a December 13th on-line paper in the...
NEW YORK (Reuters Health) – More children with bipolar I disorder (manic or mixed phase) respond to the antipsychotic risperidone than to lithium or the anticonvulsant divalproex sodium, a multicenter team reports in the Archives of General...
NEW YORK (Reuters Health) – For the nonsurgical management of first-trimester miscarriage, delayed medical treatment (i.e., monitoring for expulsion followed, if needed, by mifepristone and/or misoprostol) “may not be a reasonable option,”...
NEW YORK (Reuters Health) – In methamphetamine-dependent adults, treatment with the anticonvulsant topiramate (Topamax; Ortho-McNeil Neurologics) does little to promote abstinence, but it seems to help those on the road to abstinence, according to...
NEW YORK (Reuters Health) – Based on the 2010 American Diabetes Association’s definition of prediabetes, the condition is present in over a third of psychiatric inpatients treated with antipsychotic drugs, according to a report in the Journal of Clinical Psychiatry online December 27.
“The excess in...
NEW YORK (Reuters Health) – After stabilization with aripiprazole therapy, children with bipolar disorder may continue to benefit from maintenance treatment with the atypical antidepressant, according to the results of a double-blind, placebo-controlled trial reported in the Journal of Clinical Psychiatry...
NEW YORK (Reuters Health) – Buprenorphine-naloxone (Suboxone, Reckitt-Benckiser) helps curb prescription opioid dependence, but counseling does little to boost success rates, according to results of a randomized controlled trial published online today in Archives of General Psychiatry.
The study found...